The current earnings forecast score of Inmode Ltd is 6.67, ranking 162 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 16.00, with a high of 21.00 and a low of 15.00.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
15.333
Target Price
+1.28%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Inmode Ltd
INMD
6
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Inmode Ltd's expected revenue for the next quarter?
Inmode Ltd's expected revenue is 93.03M.
What is Inmode Ltd's price target?
Analysts forecast that Inmode Ltd's price target is USD 16.00, with the highest forecast at USD 21.00 and the lowest forecast at USD 15.00.
How have Inmode LtdINMD's recent earnings per share performed?
The market expectation was USD 0.18, while Inmode LtdINMD's earnings per share (EPS) for the previous quarter was USD 0.43. EPS for the next quarter is expected at USD 0.33.
What is the analyst rating for Inmode Ltd?
Based on the ratings of Inmode Ltd's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.